MMP-9 Protein May Be Biomarker Of Progressive Multifocal Leukoencephalopathy Development In Patients With Relapsing-Remitting Multiple Sclerosis Treated With Natalizumab, Study Indicates.
				
				February 13, 2019
				
					Multiple Sclerosis News Today (2/12, Grinstein) reports researchers found that the MMP-9 protein may be a predictive biomarker “of progressive multifocal leukoencephalopathy development in patients with relapsing-remitting multiple sclerosis (RRMS) who ar...